| Dec 7, 2011
| 11:20 AM
Hospitals nationwide are experiencing shortages of critical generic intravenous drugs. We believe a fundamental reason for this national shortage is government price controls. With these limits, there is little incentive to invest in new facilities and...
| Jan 23, 2011
This year is shaping up as a gratifying one for Allergan, the big Irvine company known for Botox and breast implants.
The leading manufacturer of gastric bands, which are surgically implanted around the stomach to suppress the appetite of extremely...
| Jun 15, 2011
| 4:42 AM
New labeling rules for sunscreens should make it easier for U.S. consumers to choose products that will protect them from sunburn, skin cancer and premature aging.
The U.S. Food and Drug Administration ruled on Tuesday that sunscreens making those claims...
| Aug 10, 2011
| 10:55 AM
LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
A pivotal trial found...
| Aug 28, 2011
| 7:37 AM
PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.
Although Eliquis will...
| Sep 7, 2011
| 9:21 AM
LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.
| Sep 26, 2011
| 8:30 PM
(Reuters) - Johnson & Johnson has told doctors it expects a limited supply of its Doxil cancer drug to become available within the next six weeks, but warned the amount would not be sufficient for all patients currently on waiting lists.
| Sep 27, 2012
Three generations of the Johnson family took up professional photography. Which means they have 80 years of Chicago stories to share.
Jeff Johnson was born with photography in his blood. It just took him a while to discover it.
| Jan 13, 2009
You might conclude that stock dividends are harder to find these days than, say, a credit card company that forgives late payments.
Cash-strapped companies, most notably banks, slashed dividends last year to the tune of more than $40 billion.
It was the...
| May 1, 2009
Sunscreen is commonly hailed as safe, essential body armor. It protects us from blistering sunburn, keeps our skin from wrinkling and helps guard against squamous cell cancer.
But the evidence is inconclusive as to whether sunscreens reduce the risk of...
| Dec 2, 2009
This may be hard to fathom, but I have been away from the oasis that is IndySportsNation the past couple days, just not physically in the office (once in the Nation, always in the Nation, and believe it or not, you can be kicked out of the Hell's Angels)....